Eli Lilly (NYSE:LLY) may not have been the top-performing large-cap pharmaceutical stock, but its performance this year is nothing to sneeze at. As of this writing, LLY stock has soared nearly 35.5% since the start of 2022. After delivering such outsized gains during a bear market, some may be concerned that LLY will deliver middling
0 Comments
In the coming year, the best industrial stocks to buy will have the staying power to resist recessionary headwinds. If you’re looking for new opportunities in 2023, you’ve got to be a little excited about industrial stocks. A down market stings today but buying stocks when they’re a little beaten down is the quickest way to
0 Comments
Todd Bunton, CFA, Growth & Income Stock Strategist at Zacks Investment Research, discusses a stock that might be worth a closer look by investors: DineEquity (DIN). This restaurant company recently delivered solid second quarter results, driven by the strongest same-store sales growth at its IHOP brand in over a decade. Analysts revised their estimates higher
0 Comments
With a contentious time in 2022 coming to a close, it may be helpful to look back and consider the most sold-off stocks last year. Similar to learning from prior mistakes, investors may be able to garner lessons from the worst-hit market ideas. Basically, these are companies that currently sit just a few steps away
0 Comments